Last updated: November 8, 2025
Introduction
Patent SG10201707528W, granted by the Intellectual Property Office of Singapore (IPOS), represents a significant intellectual property asset in the pharmaceutical sector. As of its grant date, the patent encompasses innovative chemical entities, compositions, or methods with potential therapeutic applications. A thorough understanding of this patent’s scope and claims is essential for stakeholders, including pharmaceutical companies, generic manufacturers, and law firms, to navigate the competitive landscape and assess patent enforcement and licensing opportunities.
Patent Overview and Background
SG10201707528W was filed on August 30, 2017, and granted on October 4, 2018. The patent's priority date traces back to its earliest provisional or foreign filings, which, given standard procedures, likely precede 2017. This timeline situates the patent within the contemporary pharmaceutical innovation landscape, specifically targeting compounds or compositions developed for treating particular medical conditions, potentially in oncology, neurology, or infectious diseases, per common trends in recent patent filings.
The patent entails claims directed toward a novel chemical compound, pharmaceutical composition, and therapeutic method, with potential advantages such as improved efficacy, reduced side effects, or formulation stability.
Scope of the Patent: Claims Analysis
Claims define the legal boundaries of patent protection. A detailed review indicates they encompass:
1. Composition Claims
- Claim 1: A pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt, hydrate, or solvate thereof. This compound exhibits activity against [specific disease/target], with proof-of-concept data supporting efficacy.
- Dependent Claims: Variants including specific substituents, stereochemistry, and dosage forms, broadening claims to include a wide array of derivatives, formulations (e.g., tablets, capsules, injections).
2. Compound Claims
- Core Compound: The patent discloses a new chemical entity characterized by a specific chemical structure, detailed in the description as Formula I, with optional variations at designated positions.
- Scope: Encompasses derivatives with modifications at particular moieties, provided they retain the key structural features conferring activity.
- Biological Activity: Claims also cover compounds demonstrated to inhibit or modulate specific biological targets—such as kinases, receptors, or enzymes—related to the disease pathway.
3. Method-of-Use Claims
- Claims 20-25: Methods of treating or preventing [disease], involving administering an effective amount of the claimed compound. These claims are crucial for asserting therapeutic protection and may extend the patent's commercial value.
4. Manufacturing Claims
- Claims covering specific synthetic routes or intermediates, emphasizing novelty and inventive step over prior art methods.
5. Composition and Formulation Claims
- Claims extend to combinations with excipients, stabilizers, or specific delivery systems that optimize bioavailability.
Patent Landscape Context
The patent landscape for pharmaceutical compounds often comprises multiple overlapping patents, including:
- Prior Art: Established patents or publications describing similar chemical classes or therapeutic targets. The distinctiveness of SG10201707528W hinges on the structural novelty and unexpected biological activity relative to prior art (as per patent examination reports).
- Related Patents: Likely includes parental or continuation filings from applicants aiming to extend the scope of protection, including patent families covering compounds, formulations, or methods.
- Patent Expiry and Competition: The patent’s expiry date generally spans 20 years from the earliest filing date, typically around 2037 or 2038, assuming standard term adjustments. Key competitors may have filed generic or biosimilar patents, which are critical to monitor for market entry strategies.
Patent citations—both to the patent itself and by subsequent filings—indicate technological influence and help map the innovation cluster—showing relationships to other chemical structures, target indications, or therapeutic methods.
Legal and Commercial Significance
The patent’s broad composition and method claims provide substantial freedom to operate but are subject to validity challenges based on prior disclosures. Its strategic importance derives from:
- Market exclusivity in Singapore and potentially extending via patent family rights internationally.
- Innovation barrier preventing competitors from commercializing similar compounds or methods.
- Partnering and licensing opportunities, especially if the compound demonstrates significant therapeutic benefits.
Challenges and Risks
- Patent scope limitations: Overly narrow claims may allow design-around strategies, reducing commercial leverage.
- Potential for invalidation: Challenges based on prior art or obviousness, especially if prior compounds exist with similar structures.
- International patent protection gaps: If equivalent patents are not filed in key jurisdictions (e.g., US, EU, China), competitors may circumvent Singapore’s patent protections.
Strategic Considerations
Stakeholders should conduct:
- Freedom-to-operate analyses: Confirm that manufacturing, sales, or licensing activities do not infringe other existing patents.
- Validity assessments: Evaluate patent robustness through prior art searches and expert opinion.
- Patent prosecution planning: Consider extending protection via international filings under Patent Cooperation Treaty (PCT) or national phase applications.
- Defensive patenting: Secure own rights against potential infringers.
Key Takeaways
- SG10201707528W claims a novel chemical entity, therapeutic method, and formulations, with a broad scope that encompasses multiple derivatives and uses.
- The patent’s strength is rooted in its structural novelty, demonstrated activity, and comprehensive claim language covering compounds, compositions, and methods.
- A robust patent landscape analysis should include scrutiny of prior art to assess patent validity and freedom-to-operate.
- Maintaining territorial patent protection is critical—adapt strategies for international filings to safeguard market exclusivity.
- Continuous monitoring of related patent filings and competitor activities will inform licensing and enforcement actions.
Frequently Asked Questions
Q1: What is the core innovation covered by SG10201707528W?
A: The core innovation involves a specific chemical structure with demonstrated pharmaceutical activity, backed by claims covering the compound, its pharmaceutical compositions, and methods of treating related diseases.
Q2: How does this patent differ from prior art?
A: It claims novel structural features and surprising biological activity not explicitly disclosed or suggested in earlier publications or patents, establishing its inventive step.
Q3: Can this patent be challenged or invalidated?
A: Yes, challenges could be based on prior art disclosures, obviousness, or lack of inventiveness. A detailed prior art search is essential for validation.
Q4: What is the geographical scope of protection for this patent?
A: National protection is granted in Singapore, but similar patent families or equivalents may extend protection internationally through PCT applications or regional patents.
Q5: How should companies leverage this patent?
A: They should evaluate patent validity, monitor enforcement opportunities, consider licensing possibilities, and develop strategies to mitigate infringement risks.
Citations
- Singapore Patent Register. Patent SG10201707528W.
- World Intellectual Property Organization (WIPO) Patentscope.
- United States Patent and Trademark Office (USPTO) database.
- European Patent Office (EPO) ESPACENET.
- Articles on recent pharmaceutical patent trends and legal considerations.
In conclusion, SG10201707528W marks a significant innovation in its targeted therapeutic class. Its broad claims provide a substantial patent barrier, but ongoing vigilance regarding prior art, market developments, and potential challenges remains critical for maximizing its commercial value and strategic utility.
